Blog
RSS FeedPosted by Michael Wonder on 15 Aug 2016
NHS patients missing out on cancer drugs
15 August 2016 - Thousands of NHS patients in the UK are missing out on access to innovative treatments that are ...
Posted by Michael Wonder on 14 Aug 2016
Gigantism sufferers to benefit from new miracle drug subsidy
14 August 2016 - Australians who suffer from a rare disease that causes gigantism will benefit from a Turnbull government subsidy ...
Posted by Michael Wonder on 14 Aug 2016
Type 2 diabetes boost: new treatment will save money and multiple injections
14 August 2016 - Thousands of Australians with type 2 diabetes mellitus will soon be able to have one injection a ...
Posted by Michael Wonder on 12 Aug 2016
CADTH issues initial pERC outcome for Lynparza (olaparib)
5 August 2016 - CADTH has published pERC's initial recommendation on the use of olaparib for use as monotherapy maintenance treatment ...
Posted by Michael Wonder on 12 Aug 2016
Thousands to benefit as NICE set to recommend drug to prevent heart attacks and strokes
12 August 2016 - NICE has published draft guidance recommending anti-clotting drug ticagrelor 60 mg with aspirin for people who have ...
Posted by Michael Wonder on 12 Aug 2016
CADTH calls for patient input on submission from Janssen for Stelara (ustekinumab)
12 August 2016 - CADTH has received notice of a pending submission from Janssen for ustekinumab for use by patients with ...
Posted by Michael Wonder on 12 Aug 2016
PBS and RPBS Section 85 date of processing and date of supply data
12 August 2016 - The PBS and RPBS Section 85 date of processing and date of supply data has now been ...
Posted by Michael Wonder on 11 Aug 2016
A novel UK approach to cancer access: yes, no, or maybe?
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
Posted by Michael Wonder on 11 Aug 2016
1 September 2016 changes to PBS efficient funding of chemotherapy
11 August 2016 - From 1 September 2016, approved suppliers will need to provide additional information when claiming eligible efficient funding ...
Posted by Michael Wonder on 11 Aug 2016
CADTH provides an update on its therapeutic review of new drugs for type 2 diabetes mellitus
10 August 2016 - CADTH is undertaking a project to assess the clinical and cost-effectiveness of new drugs for the treatment ...
Posted by Michael Wonder on 10 Aug 2016
Cancer patients may lose vital drug in crackdown on funding: watchdog reviews 31 treatments that are not usually available on the NHS
10 August 2016 - The drug brentuximab vedotin may no longer be provided on the NHS. ...
Posted by Michael Wonder on 10 Aug 2016
PBAC Drug Utilisation Sub Committee outcome statement
10 August 2016 - The outcome statement from the PBAC Drug Utilisation Sub Committee June 2016 meeting is now available. ...
Posted by Michael Wonder on 10 Aug 2016
Proposal to award sole supply of venlafaxine hydrochloride
10 August 2016 - PHARMAC is seeking feedback on a proposal to award sole supply status in the community for venlafaxine hydrochloride ...
Posted by Michael Wonder on 09 Aug 2016
Adaptive pathways: EMA still leaves open questions unanswered
9 August 2016 - Current EMA report on the pilot project again documents perplexity regarding the use of “real world data”. ...
Posted by Michael Wonder on 09 Aug 2016
NICE issues draft guidance on the use of talimogene laherparepvec
9 August 2016 - Talimogene laherparepvec (Imlygic) is the first cellular therapy to be appraised by NICE. ...